UBS Maintains Neutral on Bath & Body Works, Raises Price Target to $52
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Jay Sole maintains a Neutral rating on Bath & Body Works (NYSE:BBWI) and raises the price target from $46 to $52.
March 04, 2024 | 11:59 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UBS analyst Jay Sole maintains a Neutral rating on Bath & Body Works and raises the price target from $46 to $52.
The increase in price target by UBS suggests a positive outlook on Bath & Body Works' stock value in the short term, despite maintaining a Neutral rating. This adjustment reflects an expectation of stronger performance or favorable market conditions for BBWI, potentially leading to increased investor interest and a positive impact on the stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90